Dysregulated expression of MIC-1/PDF in human prostate tumor cells

Dev Karan, Siu Ju Chen, Sonny L. Johansson, Ajay P. Singh, Vishwas M. Paralkar, Ming-Fong Lin, Surinder Kumar Batra

Research output: Contribution to journalArticle

51 Citations (Scopus)

Abstract

As a part of the study to identify genes associated with hormone-refractory stage of human prostate cancer, we have recently identified several genetic and epigenetic changes that seem to be associated with the progression of androgen-sensitive to androgen-independent prostate tumor cells. In the present study, we report a novel gene, macrophage inhibitory cytokine-1 (MIC-1) also known as prostate derived factor (PDF), that was highly expressed in androgen-independent LNCaP-C81 cells and its metastatic variant LNCaP-Ln3 compared to androgen-sensitive LNCaP-C33 cells. The MIC-1/PDF expression was dysregulated (very low to non-detectable) in the androgen-independent PC3 and DU145 cells. Interestingly, serum factors demonstrated a differential regulation of MIC-1/PDF in the androgen-sensitive and the androgen-independent cells of LNCaP cells. Immunohistochemical analysis on 15 prostatic adenocarcinomas showed a weak staining in the benign prostatic glandular area (intensity score 2.38±0.25; n=13), while the immunoreactivity was significantly stronger (p<0.05) in areas of adenocarcinoma (score 7.33±0.88; n=15). Altogether, these data suggest that the serum factors (including androgens and cytokines) might contribute to the regulation of the MIC-1/PDF gene that seems to be associated with the progression of prostate cancer.

Original languageEnglish (US)
Pages (from-to)598-604
Number of pages7
JournalBiochemical and Biophysical Research Communications
Volume305
Issue number3
DOIs
StatePublished - Jun 6 2003

Fingerprint

Growth Differentiation Factor 15
Androgens
Tumors
Prostate
Cells
Neoplasms
Genes
Prostatic Neoplasms
Adenocarcinoma
Serum
Epigenomics
Refractory materials
Hormones
Staining and Labeling
Cytokines

Keywords

  • Immunohistochemistry
  • LNCaP cell model
  • MIC-1/PDF
  • Prostate cancer

ASJC Scopus subject areas

  • Biophysics
  • Biochemistry
  • Molecular Biology
  • Cell Biology

Cite this

Dysregulated expression of MIC-1/PDF in human prostate tumor cells. / Karan, Dev; Chen, Siu Ju; Johansson, Sonny L.; Singh, Ajay P.; Paralkar, Vishwas M.; Lin, Ming-Fong; Batra, Surinder Kumar.

In: Biochemical and Biophysical Research Communications, Vol. 305, No. 3, 06.06.2003, p. 598-604.

Research output: Contribution to journalArticle

Karan, Dev ; Chen, Siu Ju ; Johansson, Sonny L. ; Singh, Ajay P. ; Paralkar, Vishwas M. ; Lin, Ming-Fong ; Batra, Surinder Kumar. / Dysregulated expression of MIC-1/PDF in human prostate tumor cells. In: Biochemical and Biophysical Research Communications. 2003 ; Vol. 305, No. 3. pp. 598-604.
@article{71fe7ac9867643bd885ffa840378a15d,
title = "Dysregulated expression of MIC-1/PDF in human prostate tumor cells",
abstract = "As a part of the study to identify genes associated with hormone-refractory stage of human prostate cancer, we have recently identified several genetic and epigenetic changes that seem to be associated with the progression of androgen-sensitive to androgen-independent prostate tumor cells. In the present study, we report a novel gene, macrophage inhibitory cytokine-1 (MIC-1) also known as prostate derived factor (PDF), that was highly expressed in androgen-independent LNCaP-C81 cells and its metastatic variant LNCaP-Ln3 compared to androgen-sensitive LNCaP-C33 cells. The MIC-1/PDF expression was dysregulated (very low to non-detectable) in the androgen-independent PC3 and DU145 cells. Interestingly, serum factors demonstrated a differential regulation of MIC-1/PDF in the androgen-sensitive and the androgen-independent cells of LNCaP cells. Immunohistochemical analysis on 15 prostatic adenocarcinomas showed a weak staining in the benign prostatic glandular area (intensity score 2.38±0.25; n=13), while the immunoreactivity was significantly stronger (p<0.05) in areas of adenocarcinoma (score 7.33±0.88; n=15). Altogether, these data suggest that the serum factors (including androgens and cytokines) might contribute to the regulation of the MIC-1/PDF gene that seems to be associated with the progression of prostate cancer.",
keywords = "Immunohistochemistry, LNCaP cell model, MIC-1/PDF, Prostate cancer",
author = "Dev Karan and Chen, {Siu Ju} and Johansson, {Sonny L.} and Singh, {Ajay P.} and Paralkar, {Vishwas M.} and Ming-Fong Lin and Batra, {Surinder Kumar}",
year = "2003",
month = "6",
day = "6",
doi = "10.1016/S0006-291X(03)00823-4",
language = "English (US)",
volume = "305",
pages = "598--604",
journal = "Biochemical and Biophysical Research Communications",
issn = "0006-291X",
publisher = "Academic Press Inc.",
number = "3",

}

TY - JOUR

T1 - Dysregulated expression of MIC-1/PDF in human prostate tumor cells

AU - Karan, Dev

AU - Chen, Siu Ju

AU - Johansson, Sonny L.

AU - Singh, Ajay P.

AU - Paralkar, Vishwas M.

AU - Lin, Ming-Fong

AU - Batra, Surinder Kumar

PY - 2003/6/6

Y1 - 2003/6/6

N2 - As a part of the study to identify genes associated with hormone-refractory stage of human prostate cancer, we have recently identified several genetic and epigenetic changes that seem to be associated with the progression of androgen-sensitive to androgen-independent prostate tumor cells. In the present study, we report a novel gene, macrophage inhibitory cytokine-1 (MIC-1) also known as prostate derived factor (PDF), that was highly expressed in androgen-independent LNCaP-C81 cells and its metastatic variant LNCaP-Ln3 compared to androgen-sensitive LNCaP-C33 cells. The MIC-1/PDF expression was dysregulated (very low to non-detectable) in the androgen-independent PC3 and DU145 cells. Interestingly, serum factors demonstrated a differential regulation of MIC-1/PDF in the androgen-sensitive and the androgen-independent cells of LNCaP cells. Immunohistochemical analysis on 15 prostatic adenocarcinomas showed a weak staining in the benign prostatic glandular area (intensity score 2.38±0.25; n=13), while the immunoreactivity was significantly stronger (p<0.05) in areas of adenocarcinoma (score 7.33±0.88; n=15). Altogether, these data suggest that the serum factors (including androgens and cytokines) might contribute to the regulation of the MIC-1/PDF gene that seems to be associated with the progression of prostate cancer.

AB - As a part of the study to identify genes associated with hormone-refractory stage of human prostate cancer, we have recently identified several genetic and epigenetic changes that seem to be associated with the progression of androgen-sensitive to androgen-independent prostate tumor cells. In the present study, we report a novel gene, macrophage inhibitory cytokine-1 (MIC-1) also known as prostate derived factor (PDF), that was highly expressed in androgen-independent LNCaP-C81 cells and its metastatic variant LNCaP-Ln3 compared to androgen-sensitive LNCaP-C33 cells. The MIC-1/PDF expression was dysregulated (very low to non-detectable) in the androgen-independent PC3 and DU145 cells. Interestingly, serum factors demonstrated a differential regulation of MIC-1/PDF in the androgen-sensitive and the androgen-independent cells of LNCaP cells. Immunohistochemical analysis on 15 prostatic adenocarcinomas showed a weak staining in the benign prostatic glandular area (intensity score 2.38±0.25; n=13), while the immunoreactivity was significantly stronger (p<0.05) in areas of adenocarcinoma (score 7.33±0.88; n=15). Altogether, these data suggest that the serum factors (including androgens and cytokines) might contribute to the regulation of the MIC-1/PDF gene that seems to be associated with the progression of prostate cancer.

KW - Immunohistochemistry

KW - LNCaP cell model

KW - MIC-1/PDF

KW - Prostate cancer

UR - http://www.scopus.com/inward/record.url?scp=0038578603&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0038578603&partnerID=8YFLogxK

U2 - 10.1016/S0006-291X(03)00823-4

DO - 10.1016/S0006-291X(03)00823-4

M3 - Article

C2 - 12763036

AN - SCOPUS:0038578603

VL - 305

SP - 598

EP - 604

JO - Biochemical and Biophysical Research Communications

JF - Biochemical and Biophysical Research Communications

SN - 0006-291X

IS - 3

ER -